Inhibitor Therapeutics (INTI) Dividends payables (2018 - 2022)
Inhibitor Therapeutics' Dividends payables came in at $250,413 for Q3 2022, up 396.7% from $50,411 a year earlier and up 25.2% from the prior quarter.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Dividends payables (2018 - 2022) Analysis & Trends
At the end of FY2021, Inhibitor Therapeutics' Dividends payables was $100,823, unchanged from FY2020.
- Dividends payables carries a three-year compound annual growth rate of 0.3% (FY2018 to FY2021).
- Going back by year, Dividends payables was $100,822 in FY2020 (unchanged), $100,822 in FY2019 (+0.9%) and $99,945 in FY2018.
- The Q3 2022 figure represents the highest quarterly Dividends payables in data going back to Q1 2018.
- Year-over-year, Dividends payables has increased for three consecutive quarters, with growth averaging 73.1% over the last eight quarters.
- The fastest year-over-year change in Dividends payables over five years came in Q3 2022 (growth of 396.7%), and the weakest in Q1 2021 (a decline of 67.3%).
- Business Quant data shows INTI's Dividends payables at $200,002 (Q2 2022), $150,138 (Q1 2022) and $100,823 (Q4 2021) in the three quarters before Q3 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 2.13 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.45 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Inhibitor Therapeutics | 17.38 Mn | 17.38 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 250,413.00 |
| Jun 30, 2022 | 200,002.00 |
| Mar 31, 2022 | 150,138.00 |
| Dec 31, 2021 | 100,823.00 |
| Sep 30, 2021 | 50,411.00 |
| Jun 30, 2021 | 99,178.00 |
| Mar 31, 2021 | 49,315.00 |
| Dec 31, 2020 | 100,822.00 |
| Sep 30, 2020 | 50,411.00 |
| Jun 30, 2020 | 200,548.00 |
| Mar 31, 2020 | 150,685.00 |
| Dec 31, 2019 | 100,822.00 |
| Sep 30, 2019 | 50,410.00 |
| Jun 30, 2019 | 99,178.00 |
| Mar 31, 2019 | 49,315.00 |
| Dec 31, 2018 | 99,945.00 |
| Sep 30, 2018 | 49,534.00 |
| Jun 30, 2018 | 56,548.00 |
| Mar 31, 2018 | 26,630.00 |
API Access
Inhibitor Therapeutics Dividends payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=dividends-payables&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "dividends-payables", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=dividends-payables&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();